Age as a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients With Patent Foramen Ovale

Stroke - United States
doi 10.1161/01.str.0000135773.24116.18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Patent Foramen Ovale and Cryptogenic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2013English

Ovarian Cancer Presenting as Cryptogenic Stroke From Patent Foramen Ovale

Clinical Medicine and Research
MedicineHome CareCommunity
2019English

Patent Foramen Ovale in Cryptogenic Stroke: Not to Close

Circulation
Cardiovascular MedicinePhysiologyCardiology
2008English

Patent Foramen Ovale in Cryptogenic Stroke: Diagnosis and Treatment

Journal of Neurosonology and Neuroimaging
2018English

Patent Foramen Ovale and Atrial Septal Aneurysm in Cryptogenic Stroke

Postgraduate Medical Journal
Medicine
2007English

Patent Foramen Ovale and Cryptogenic Stroke: Diagnosis and Updates in Secondary Stroke Prevention

Stroke and Vascular Neurology
NeurologyCardiovascular MedicineCardiology
2018English

Patent Foramen Ovale and Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2004English

PFO or UFO: How Good Is Transesophageal Echocardiography in Identifying Patent Foramen Ovale as the Cause of a Cryptogenic Stroke?

Circulation. Cardiovascular imaging
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2014English

S Patent Foramen Ovale and Cryptogenic Stroke – A Statistical or Cause-And-Effect Relationship? A Neurological Point of View

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy